Company Information

  

Address: ONE MEADOWLANDS PLZ  
City: E RUTHERFORD 
State: NJ 
Zip Code: 07073 
Telephone: 201-804-3000 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Cambrex Corporation (the "Company" or "Cambrex"), a Delaware corporation, began business in December 1981. Cambrex is a life sciences company that provides products and services that accelerate and improve the development and commercialization of new and generic therapeutics. The Company primarily supplies its products and services worldwide to innovator and generic pharmaceutical companies. The Company's overall strategy is to: grow its portfolio of custom development projects, especially those in the later stages of the clinical trial process; secure long-term supply agreements to produce active pharmaceutical ingredients ("APIs") and intermediates for newly approved drug products; expand sales of products and projects based on its proprietary technologies; partner with generic drug companies to grow the Company's extensive portfolio of generic APIs; and develop, or co-develop with partners, a portfolio of niche generic drug products in finished dosage form.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/20172.94NA20.32
03/20172.83NA19.45
12/20162.65NA20.36
09/20162.12NA20.97
06/20162.07NA24.99
03/20162.03NA21.67
12/20151.76NA26.76
09/20152.11NA18.81

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity0.57Total Liab/Total Assets0.34
Net Inc/Total Assets0.13Total Liab/Inv Cap0.40
Net Inc/Inv Cap0.16Total Liab/Comm Equity1.44
Pretax Inc/Net Sales0.26Interest Coverage Ratio178.88
Net Inc/Net Sales0.17Curr Debt/EquityNA
Cash Flow/Net Sales0.25LTD/EquityNA
SG&A/NetSales0.12Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover4.55Quick Ratio2.09
Inventory Turnover2.46Current Ratio3.38
Inventory Day Sales0.01Net Rec/Curr Assets0.36
Net Sales/Work Cap2.16Inv/Curr Assets0.38
Net Sales/PP&E2.26  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 134.55 105.01 177.87 99.40
Cost of Goods Sold 77.05 58.18 98.70 61.80
Selling & Admin Exps 18.48 15.75 17.82 14.95
Operating Income 34.56 27.18 56.69 19.46
Interest Exp NA NA 0.36 0.36
Pretax Income 34.30 26.93 56.38 19.16
Other Income 0.13 0.01 0.05 0.07
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 25.03 19.87 37.38 9.22

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 94.18 99.17 74.14 90.74
Receivables - Total 108.07 76.19 117.37 45.38
Inventories - Total 156.58 151.53 123.18 143.89
Total Current Assets 366.24 332.80 322.66 289.02
Net Property, Plant & Equipment 237.80 223.77 217.09 209.21
Total Assets 673.08 627.48 611.87 555.06
Liabilities        
Accounts Payable 80.59 79.06 87.96 73.69
Debt in Current Liabilities NA NA 0.00 0.00
Total Current Liabilities 88.36 84.94 95.46 78.92
Long-Term Debt NA NA NA NA
Total Liabilities 202.52 196.96 206.44 188.12
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 3.42 3.40 3.39 3.37
Retained Earnings 372.27 347.24 327.38 289.99
Treasury Stock -12.22 -12.22 -13.50 -13.59
Total Stockholders' Equity 470.56 430.52 405.43 366.94
Total Liabilities and Stockholders' Equity 673.08 627.48 611.87 555.06

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities 1.09 35.99 11.44 46.44
Net Cash Provided by Investing Activities -10.69 -12.17 -36.28 -11.15
Net Cash Provided by Financing Activities 2.25 0.73 10.15 3.12

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/2012276.5062.302.09
12/2013318.1825.920.98
12/2014374.6157.301.84
12/2015433.3357.221.76
12/2016490.6481.682.65
Growth Rates15.427.006.11

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1727433,789--




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.